The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu

The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu

Currently, there is a urgent need to search for new diagnostic methods that allow us to reveal malignant tumors with the overexpression of Her-2/neu with high accuracy. In recent years radioisotope methods have been actively developing to identify specific tumor targets, with antibodies being the “t...

Full description

Bibliographic Details
Main Authors: Olga D. Bragina, Maria S. Larkina, Elena S. Stasyuk, Vladimir I. Chernov, Mekhman S. Yusubov, Victor S. Skuridin, Sergei M. Deyev, Roman V. Zel’chan, Michael A. Buldakov, Ekaterina V. Podrezova, M. V. Belousov
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2017-10-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
darpin
technetium-99m
chelating agent
her-2/neu
molecular imaging
breast cancer
Online Access:https://bulletin.tomsk.ru/jour/article/view/952

Internet

https://bulletin.tomsk.ru/jour/article/view/952

Similar Items